Skip to content

Evaluation of the effectiveness of medication literacy intervention programs for glaucoma patients

Evaluation of the effectiveness of medication literacy intervention programs for glaucoma patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070522
Enrollment
Unknown
Registered
2023-04-14
Start date
2023-04-30
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Intervention group:The control group was intervened by routine follow-up and education procedures for glaucoma outpatients, and the intervention group implemented the medication literacy intervention
Control group:The control group was intervened by routine follow-up and education procedures for glaucoma outpatients

Sponsors

The First Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Voluntary participation in this research (2) Diagnosed with glaucoma according to the "Chinese Glaucoma Guidelines" (3) Clear consciousness, no cognitive dysfunction (4) Be able to communicate or read normally (5) Age= 18 years old and = 70 years old (6) Receiving glaucoma drug for at least 2 weeks (7) Will use smartphones and WeChat

Exclusion criteria

Exclusion criteria: (1) Suffering from serious chronic diseases and complications (2) Currently engaged in medical-related work or before retirement (3) Unclear speech or lack of cooperation

Design outcomes

Primary

MeasureTime frame
Level of medication literacy in patients with glaucoma;

Secondary

MeasureTime frame
Medication compliance in patients with glaucoma;medication self-efficacy;Intraocular pressure (IOP) in patients with glaucoma;

Countries

China

Contacts

Public ContactWang Lihua

The First Affiliated Hospital of the Army Medical University

773569612@qq.com+86 13808318988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026